Caspofungin Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Injection
Available Strengths: 50 mg, 70 mg (single-use vials)
Reference Brands: Cancidas (US & EU)
Category:
Critical Care
Caspofungin IV treats serious fungal infections like candidemia and aspergillosis. Available in 50 mg and 70 mg lyophilized vials, it’s sold as Cancidas and via leading generics. Pharma B2B platforms support global bulk procurement of Caspofungin for hospitals, ICUs, and healthcare systems managing life-threatening mycoses.
Caspofungin is available in Intravenous (IV) Injection
and strengths such as 50 mg, 70 mg (single-use vials).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Caspofungin is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Caspofungin can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Caspofungin is an echinocandin antifungal used for treating invasive fungal infections such as candidemia, intra-abdominal candidiasis, and invasive aspergillosis in patients unresponsive to other therapies. It is available as a lyophilized powder for IV injection in 50 mg and 70 mg strengths. In the US, Caspofungin is marketed under the brand Cancidas by Merck and also supplied by generic manufacturers like Fresenius, Accord, and Mylan. In the EU, Cancidas and equivalent generics are distributed by Sandoz and others. Pharma B2B platforms enable reliable, large-scale sourcing of Caspofungin for hospitals and intensive care settings treating high-risk fungal infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing